Insider Trading History of Shakil Ian

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Shakil Ian since 2024. This trader's CIK number is 1826129. At the time of last reporting, Shakil Ian was the CHIEF STRATEGY OFFICER of Augmedix, Inc.. (stock ticker symbol AUGX). Also see all insider trading activities at Augmedix, Inc..


Yearly summary of insider trading at Augmedix, Inc. (AUGX) by Shakil Ian

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 AUGX 0 $0 442,781 $1,771,971 203,990 $144,704


Insider trading of Augmedix, Inc. (AUGX) by Shakil Ian

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-08-15 AUGX Option Ex 3,750 .00 0
2024-08-15 AUGX Option Ex 3,750 .00 0
2024-05-15 AUGX Sale 1,387 1.19 1,650
2024-05-15 AUGX Option Ex 3,750 .00 0
2024-04-15 AUGX Sale 500 3.80 1,900
2024-04-15 AUGX Option Ex 500 .86 430
2024-04-12 AUGX Option Ex 19,544 .86 16,807
2024-04-12 AUGX Sale 19,544 3.82 74,599
2024-04-09 AUGX Option Ex 31,542 .75 23,656
2024-04-10 AUGX Option Ex 36,467 .86 31,361
2024-04-11 AUGX Option Ex 24,778 .86 21,309
2024-04-09 AUGX Sale 31,542 4.14 130,520
2024-04-10 AUGX Sale 36,467 3.87 141,273
2024-04-11 AUGX Sale 24,778 3.93 97,476
2024-04-05 AUGX Sale 51,387 4.03 207,243
2024-04-08 AUGX Option Ex 28,563 .64 18,280
2024-04-08 AUGX Sale 37,780 3.97 149,986
2024-04-04 AUGX Sale 64,055 4.15 265,828
2024-04-03 AUGX Sale 45,906 4.11 188,581
2024-04-01 AUGX Option Ex 51,346 .64 32,861
2024-04-01 AUGX Sale 58,978 3.96 233,316
2024-04-02 AUGX Sale 38,463 3.89 149,736
2024-03-28 AUGX Sale 31,994 4.06 129,863

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shakil Ian (CHIEF STRATEGY OFFICER of Augmedix, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.